Role of chemokine receptors and intestinal epithelial cells in the mucosal inflammation and tolerance

Journal of Leukocyte Biology

Volumn 101, Issue 2, 2017, Pages 377-394

  Kulkarni, Neeraja ^a   Pathak, Manisha ^a   Lal, Girdhari ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Autoimmunity; Colitis; Gut immunity; Inflammatory bowel disease; Intestinal epithelial barrier

Indexed keywords

CCL25 CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR3; EOTAXIN; EOTAXIN 2; EOTAXIN 3; FRACTALKINE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; UNCLASSIFIED DRUG;

BASOPHIL; CELL INTERACTION; CELL MIGRATION; EOSINOPHIL; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM CELL; MUCOSA INFLAMMATION; PRIORITY JOURNAL; REVIEW; ANIMAL; EPITHELIUM CELL; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTESTINE MUCOSA; METABOLISM; PATHOLOGY;

ANIMALS; EPITHELIAL CELLS; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; RECEPTORS, CHEMOKINE;

EID: 85011337857     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1RU0716-327R     Document Type: Review

References (210)

1. Salminen, S., Bouley, C., Boutron-Ruault, M. C., Cummings, J. H., Franck, A., Gibson, G. R., Isolauri, E., Moreau, M. C., Roberfroid, M., Rowland, I. (1998) Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 80 (Suppl 1), S147–S171.
2. Yan, F., Polk, D. B. (2004) Commensal bacteria in the gut: learning who our friends are. Curr. Opin. Gastroenterol. 20, 565–571.
3. Parsot, C., Sansonetti, P. J. (1996) Invasion and the pathogenesis of Shigella infections. Curr. Top. Microbiol. Immunol. 209, 25–42.
4. Jones, B. D., Ghori, N., Falkow, S. (1994) Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer’s patches. J. Exp. Med. 180, 15–23.
5. Galán, J. E. (1996) Molecular and cellular bases of Salmonella entry into host cells. Curr. Top. Microbiol. Immunol. 209, 43–60.
6. Strober, W., Fuss, I., Mannon, P. (2007) The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 117, 514–521.
7. Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nuñez, G., Flavell, R. A. (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731–734.
8. Maeda, S., Hsu, L. C., Liu, H., Bankston, L. A., Iimura, M., Kagnoff, M. F., Eckmann, L., Karin, M. (2005) Nod2 mutation in Crohn’s disease potentiates NF-kappaB activity and IL-1beta processing. Science 307, 734–738.
9. Oostenbrug, L. E., Drenth, J. P., de Jong, D. J., Nolte, I. M., Oosterom, E., van Dullemen, H. M., van der Linde, K., te Meerman, G. J., van der Steege, G., Kleibeuker, J. H., Jansen, P. L. (2005) Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm. Bowel Dis. 11, 567–575.
10. De Jager, P. L., Franchimont, D., Waliszewska, A., Bitton, A., Cohen, A., Langelier, D., Belaiche, J., Vermeire, S., Farwell, L., Goris, A., Libioulle, C., Jani, N., Dassopoulos, T., Bromfield, G. P., Dubois, B., Cho, J. H., Brant, S. R., Duerr, R. H., Yang, H., Rotter, J. I., Silverberg, M. S., Steinhart, A. H., Daly, M. J., Podolsky, D. K., Louis, E., Hafler, D. A., Rioux, J. D.; Quebec IBD Genetics Consortium; NIDDK IBD Genetics Consortium. (2007) The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun. 8, 387–397.
11. Bembridge, G. P., MacHugh, N. D., McKeever, D., Awino, E., Sopp, P., Collins, R. A., Gelder, K. I., Howard, C. J. (1995) CD45RO expression on bovine T cells: relation to biological function. Immunology 86, 537–544.
12. Gitter, A. H., Wullstein, F., Fromm, M., Schulzke, J. D. (2001) Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 121, 1320–1328.
13. Sanders, D. S. (2005) Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn’s disease. J. Clin. Pathol. 58, 568–572.
14. Blander, J. M. (2016) Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease. FEBS J. 283, 2720–2730.
15. Tetteh, P. W., Basak, O., Farin, H. F., Wiebrands, K., Kretzschmar, K., Begthel, H., van den Born, M., Korving, J., de Sauvage, F., van Es, J. H., van Oudenaarden, A., Clevers, H. (2016) Replacement of lost Lgr5-positive stem cells through plasticity of their enterocyte-lineage daughters. Cell Stem Cell 18, 203–213.
16. Potten, C. S., Loeffler, M. (1990) Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110, 1001–1020.
17. Macdonald, T. T., Monteleone, G. (2005) Immunity, inflammation, and allergy in the gut. Science 307, 1920–1925.
18. Laing, K. J., Secombes, C. J. (2004) Chemokines. Dev. Comp. Immunol. 28, 443–460.
19. Perez-Lopez, A., Behnsen, J., Nuccio, S. P., Raffatellu, M. (2016) Mucosal immunity to pathogenic intestinal bacteria. Nat. Rev. Immunol. 16, 135–148.
20. Peterson, L. W., Artis, D. (2014) Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 14, 141–153.
21. Creamer, B., Shorter, R. G., Bamforth, J. (1961) The turnover and shedding of epithelial cells. I. The turnover in the gastro-intestinal tract. Gut 2, 110–118.
22. Cheng, H., Leblond, C. P. (1974) Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am. J. Anat. 141, 537–561.
23. Schmidt, G. H., Winton, D. J., Ponder, B. A. (1988) Development of the pattern of cell renewal in the crypt-villus unit of chimaeric mouse small intestine. Development 103, 785–790.
24. Boman, B. M., Fields, J. Z., Cavanaugh, K. L., Guetter, A., Runquist, O. A. (2008) How dysregulated colonic crypt dynamics cause stem cell overpopulation and initiate colon cancer. Cancer Res. 68, 3304–3313.
25. Zimmerman, N. P., Vongsa, R. A., Wendt, M. K., Dwinell, M. B. (2008) Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflamm. Bowel Dis. 14, 1000–1011.
26. Daugherty, B. L., Siciliano, S. J., DeMartino, J. A., Malkowitz, L., Sirotina, A., Springer, M. S. (1996) Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183, 2349–2354.
27. Manousou, P., Kolios, G., Valatas, V., Drygiannakis, I., Bourikas, L., Pyrovolaki, K., Koutroubakis, I., Papadaki, H. A., Kouroumalis, E. (2010) Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies. Clin. Exp. Immunol. 162, 337–347.
28. Takahashi, K., Imaeda, H., Fujimoto, T., Ban, H., Bamba, S., Tsujikawa, T., Sasaki, M., Fujiyama, Y., Andoh, A. (2013) Regulation of eotaxin-3/CC chemokine ligand 26 expression by T helper type 2 cytokines in human colonic myofibroblasts. Clin. Exp. Immunol. 173, 323–331.
29. Pakianathan, D. R., Kuta, E. G., Artis, D. R., Skelton, N. J., Hébert, C. A. (1997) Distinct but overlapping epitopes for the interaction of a CCchemokine with CCR1, CCR3 and CCR5. Biochemistry 36, 9642–9648.
30. Ahrens, R., Waddell, A., Seidu, L., Blanchard, C., Carey, R., Forbes, E., Lampinen, M., Wilson, T., Cohen, E., Stringer, K., Ballard, E., Munitz, A., Xu, H., Lee, N., Lee, J. J., Rothenberg, M. E., Denson, L., Hogan, S. P. (2008) Intestinal macrophage/epithelial cell-derived CCL11/ eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J. Immunol. 181, 7390–7399.
31. Lampinen, M., Waddell, A., Ahrens, R., Carlson, M., Hogan, S. P. (2013) CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis. J. Leukoc. Biol. 94, 1061–1070.
32. Waddell, A., Ahrens, R., Steinbrecher, K., Donovan, B., Rothenberg, M. E., Munitz, A., Hogan, S. P. (2011) Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C (high) CCR2 (+) inflammatory monocyte/macrophage-derived CCL11. J. Immunol. 186, 5993–6003.
33. Carlson, M., Raab, Y., Peterson, C., Hällgren, R., Venge, P. (1999) Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Am. J. Gastroenterol. 94, 1876–1883.
34. Forbes, E., Murase, T., Yang, M., Matthaei, K. I., Lee, J. J., Lee, N. A., Foster, P. S., Hogan, S. P. (2004) Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J. Immunol. 172, 5664–5675.
35. Sangfelt, P., Carlson, M., Thörn, M., Lööf, L., Raab, Y. (2001) Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis. Am. J. Gastroenterol. 96, 1085–1090.
36. Blanchard, C., Wang, N., Stringer, K. F., Mishra, A., Fulkerson, P. C., Abonia, J. P., Jameson, S. C., Kirby, C., Konikoff, M. R., Collins, M. H., Cohen, M. B., Akers, R., Hogan, S. P., Assa’ad, A. H., Putnam, P. E., Aronow, B. J., Rothenberg, M. E. (2006) Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J. Clin. Invest. 116, 536–547.
37. White, G. E., Iqbal, A. J., Greaves, D. R. (2013) CC chemokine receptors and chronic inflammation—therapeutic opportunities and pharmacological challenges. Pharmacol. Rev. 65, 47–89.
38. Andres, P. G., Beck, P. L., Mizoguchi, E., Mizoguchi, A., Bhan, A. K., Dawson, T., Kuziel, W. A., Maeda, N., MacDermott, R. P., Podolsky, D. K., Reinecker, H. C. (2000) Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfatemediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine. J. Immunol. 164, 6303–6312.
39. Thomas, S., Baumgart, D. C. (2012) Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis. Inflammopharmacology 20, 1–18.
40. Combadiere, C., Ahuja, S. K., Tiffany, H. L., Murphy, P. M. (1996) Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1 (alpha), MIP-1 (beta), and RANTES. J. Leukoc. Biol. 60, 147–152.
41. Dwinell, M. B., Eckmann, L., Leopard, J. D., Varki, N. M., Kagnoff, M. F. (1999) Chemokine receptor expression by human intestinal epithelial cells. Gastroenterology 117, 359–367.
42. Mazzucchelli, L., Hauser, C., Zgraggen, K., Wagner, H. E., Hess, M. W., Laissue, J. A., Mueller, C. (1996) Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease. J. Pathol. 178, 201–206.
43. Lee, J. W., Wang, P., Kattah, M. G., Youssef, S., Steinman, L., DeFea, K., Straus, D. S. (2008) Differential regulation of chemokines by IL-17 in colonic epithelial cells. J. Immunol. 181, 6536–6545.
44. Oki, M., Ohtani, H., Kinouchi, Y., Sato, E., Nakamura, S., Matsumoto, T., Nagura, H., Yoshie, O., Shimosegawa, T. (2005) Accumulation of CCR5+ T cells around RANTES+ granulomas in Crohn’s disease: a pivotal site of Th1-shifted immune response? Lab. Invest. 85, 137–145.
45. Kim, C. H., Rott, L., Kunkel, E. J., Genovese, M. C., Andrew, D. P., Wu, L., Butcher, E. C. (2001) Rules of chemokine receptor association with T cell polarization in vivo. J. Clin. Invest. 108, 1331–1339.
46. Tokuyama, H., Ueha, S., Kurachi, M., Matsushima, K., Moriyasu, F., Blumberg, R. S., Kakimi, K. (2005) The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis. Int. Immunol. 17, 1023–1034.
47. Mencarelli, A., Cipriani, S., Francisci, D., Santucci, L., Baldelli, F., Distrutti, E., Fiorucci, S. (2016) Highly specific blockade of CCR5 inhibits leukocyte trafficking and reduces mucosal inflammation in murine colitis. Sci. Rep. 6, 30802.
48. Molon, B., Gri, G., Bettella, M., Gómez-Moutón, C., Lanzavecchia, A., Martínez A C., Mañes, S., Viola, A. (2005) T cell costimulation by chemokine receptors. Nat. Immunol. 6, 465–471.
49. Carvalho-Pinto, C., García, M. I., Gómez, L., Ballesteros, A., Zaballos, A., Flores, J. M., Mellado, M., Rodríguez-Frade, J. M., Balomenos, D., Martínez A C. (2004) Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice. Eur. J. Immunol. 34, 548–557.
50. Schutyser, E., Struyf, S., Van Damme, J. (2003) The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14, 409–426.
51. Williams, I. R. (2006) CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis. Ann. N. Y. Acad. Sci. 1072, 52–61.
52. Lee, A. Y., Eri, R., Lyons, A. B., Grimm, M. C., Korner, H. (2013) CC chemokine ligand 20 and its cognate receptor CCR6 in mucosal T cell immunology and inflammatory bowel disease: odd couple or axis of evil? Front. Immunol. 4, 194.
53. Röhrl, J., Yang, D., Oppenheim, J. J., Hehlgans, T. (2010) Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells. J. Biol. Chem. 285, 7028–7034.
54. Izadpanah, A., Dwinell, M. B., Eckmann, L., Varki, N. M., Kagnoff, M. F. (2001) Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G710–G719.
55. Yang, C. C., Ogawa, H., Dwinell, M. B., McCole, D. F., Eckmann, L., Kagnoff, M. F. (2005) Chemokine receptor CCR6 transduces signals that activate p130Cas and alter cAMP-stimulated ion transport in human intestinal epithelial cells. Am. J. Physiol. Cell Physiol. 288, C321–C328.
56. Sibartie, S., O’Hara, A. M., Ryan, J., Fanning, A., O’Mahony, J., O’Neill, S., Sheil, B., O’Mahony, L., Shanahan, F. (2009) Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria. BMC Immunol. 10, 54.
57. Cook, D. N., Prosser, D. M., Forster, R., Zhang, J., Kuklin, N. A., Abbondanzo, S. J., Niu, X. D., Chen, S. C., Manfra, D. J., Wiekowski, M. T., Sullivan, L. M., Smith, S. R., Greenberg, H. B., Narula, S. K., Lipp, M., Lira, S. A. (2000) CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12, 495–503.
58. Reboldi, A., Arnon, T. I., Rodda, L. B., Atakilit, A., Sheppard, D., Cyster, J. G. (2016) IgA production requires B cell interaction with subepithelial dendritic cells in Peyer’s patches. Science 352, aaf4822.
59. Iwasaki, A. (2003) The importance of CD11b+ dendritic cells in CD4+ T cell activation in vivo: with help from interleukin 1. J. Exp. Med. 198, 185–190.
60. A-Gonzalez, N., Bensinger, S. J., Hong, C., Beceiro, S., Bradley, M. N., Zelcer, N., Deniz, J., Ramirez, C., Diaz, M., Gallardo, G., de Galarreta, C. R., Salazar, J., Lopez, F., Edwards, P., Parks, J., Andujar, M., Tontonoz, P., Castrillo, A. (2009) Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31, 245–258.
61. Sierro, F., Dubois, B., Coste, A., Kaiserlian, D., Kraehenbuhl, J. P., Sirard, J. C. (2001) Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc. Natl. Acad. Sci. USA 98, 13722–13727.
62. Ledgerwood, L. G., Lal, G., Zhang, N., Garin, A., Esses, S. J., Ginhoux, F., Merad, M., Peche, H., Lira, S. A., Ding, Y., Yang, Y., He, X., Schuchman, E. H., Allende, M. L., Ochando, J. C., Bromberg, J. S. (2008) The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat. Immunol. 9, 42–53.
63. Lal, G., Zhang, N., van der Touw, W., Ding, Y., Ju, W., Bottinger, E. P., Reid, S. P., Levy, D. E., Bromberg, J. S. (2009) Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J. Immunol. 182, 259–273.
64. Zhang, N., Schröppel, B., Lal, G., Jakubzick, C., Mao, X., Chen, D., Yin, N., Jessberger, R., Ochando, J. C., Ding, Y., Bromberg, J. S. (2009) Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 30, 458–469.
65. Barrett, J. C., Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., Silverberg, M. S., Taylor, K. D., Barmada, M. M., Bitton, A., Dassopoulos, T., Datta, L. W., Green, T., Griffiths, A. M., Kistner, E. O., Murtha, M. T., Regueiro, M. D., Rotter, J. I., Schumm, L. P., Steinhart, A. H., Targan, S. R., Xavier, R. J., NIDDK IBD Genetics Consortium, Libioulle, C., Sandor, C., Lathrop, M., Belaiche, J., Dewit, O., Gut, I., Heath, S., Laukens, D., Mni, M., Rutgeerts, P., Van Gossum, A., Zelenika, D., Franchimont, D., Hugot, J. P., de Vos, M., Vermeire, S., Louis, E., Belgian-French IBD Consortium, Wellcome Trust Case Control Consortium, Cardon, L. R., Anderson, C. A., Drummond, H., Nimmo, E., Ahmad, T., Prescott, N. J., Onnie, C. M., Fisher, S. A., Marchini, J., Ghori, J., Bumpstead, S., Gwilliam, R., Tremelling, M., Deloukas, P., Mansfield, J., Jewell, D., Satsangi, J., Mathew, C. G., Parkes, M., Georges, M., Daly, M. J., Parkes, M., Georges, M., Daly, M. J. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat. Genet. 40, 955–962.
66. Varona, R., Cadenas, V., Flores, J., Martinez, A. C. & Marquez, G. (2003) CCR6 has a non-redundant role in the development of inflammatory bowel disease. Eur. J. Immunol. 33, 2937–2946.
67. Katchar, K., Kelly, C. P., Keates, S., O’brien, M. J., Keates, A. C. (2007) MIP-3alpha neutralizing monoclonal antibody protects against TNBSinduced colonic injury and inflammation in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G1263–G1271.
68. Förster, R., Davalos-Misslitz, A. C., Rot, A. (2008) CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8, 362–371.
69. Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Müller, I., Wolf, E., Lipp, M. (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23–33.
70. Schumann, M., Winter, S., Wichner, K., May, C., Kühl, A. A., Batra, A., Siegmund, B., Zeitz, M., Schulzke, J. D., Lipp, M., Höpken, U. E. (2012) CCR7 deficiency causes diarrhea associated with altered ion transport in colonocytes in the absence of overt colitis. Mucosal Immunol. 5, 377–387.
71. Schmausser, B., Endrich, S., Brändlein, S., Schär, J., Beier, D., Müller-Hermelink, H. K., Eck, M. (2005) The chemokine receptor CCR7 is expressed on epithelium of non-inflamed gastric mucosa, Helicobacter pylori gastritis, gastric carcinoma and its precursor lesions and upregulated by H. pylori. Clin. Exp. Immunol. 139, 323–327.
72. Agace, W. (2010) Generation of gut-homing T cells and their localization to the small intestinal mucosa. Immunol. Lett. 128, 21–23.
73. Kim, M. H., Taparowsky, E. J., Kim, C. H. (2015) Retinoic acid differentially regulates the migration of innate lymphoid cell subsets to the gut. Immunity 43, 107–119.
74. Mackley, E. C., Houston, S., Marriott, C. L., Halford, E. E., Lucas, B., Cerovic, V., Filbey, K. J., Maizels, R. M., Hepworth, M. R., Sonnenberg, G. F., Milling, S., Withers, D. R. (2015) CCR7-dependent trafficking of RORg+ ILCs creates a unique microenvironment within mucosal draining lymph nodes. Nat. Commun. 6, 5862.
75. McNamee, E. N., Masterson, J. C., Veny, M., Collins, C. B., Jedlicka, P., Byrne, F. R., Ng, G. Y., Rivera-Nieves, J. (2015) Chemokine receptor CCR7 regulates the intestinal TH1/TH17/Treg balance during Crohn’s-like murine ileitis. J. Leukoc. Biol. 97, 1011–1022.
76. McNamee, E. N., Masterson, J. C., Jedlicka, P., Collins, C. B., Williams, I. R., Rivera-Nieves, J. (2013) Ectopic lymphoid tissue alters the chemokine gradient, increases lymphocyte retention and exacerbates murine ileitis. Gut 62, 53–62.
77. Wurbel, M. A., Philippe, J. M., Nguyen, C., Victorero, G., Freeman, T., Wooding, P., Miazek, A., Mattei, M. G., Malissen, M., Jordan, B. R., Malissen, B., Carrier, A., Naquet, P. (2000) The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts doubleand single-positive thymocytes expressing the TECK receptor CCR9. Eur. J. Immunol. 30, 262–271.
78. Kunkel, E. J., Campbell, J. J., Haraldsen, G., Pan, J., Boisvert, J., Roberts, A. I., Ebert, E. C., Vierra, M. A., Goodman, S. B., Genovese, M. C., Wardlaw, A. J., Greenberg, H. B., Parker, C. M., Butcher, E. C., Andrew, D. P., Agace, W. W. (2000) Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J. Exp. Med. 192, 761–768.
79. Papadakis, K. A., Prehn, J., Nelson, V., Cheng, L., Binder, S. W., Ponath, P. D., Andrew, D. P., Targan, S. R. (2000) The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J. Immunol. 165, 5069–5076.
80. Kunkel, E. J., Campbell, D. J., Butcher, E. C. (2003) Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation 10, 313–323.
81. Svensson, M., Marsal, J., Ericsson, A., Carramolino, L., Brodén, T., Márquez, G., Agace, W. W. (2002) CCL25 mediates the localization of recently activated CD8alphabeta (+) lymphocytes to the small-intestinal mucosa. J. Clin. Invest. 110, 1113–1121.
82. Zabel, B. A., Agace, W. W., Campbell, J. J., Heath, H. M., Parent, D., Roberts, A. I., Ebert, E. C., Kassam, N., Qin, S., Zovko, M., LaRosa, G. J., Yang, L. L., Soler, D., Butcher, E. C., Ponath, P. D., Parker, C. M., Andrew, D. P. (1999) Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J. Exp. Med. 190, 1241–1256.
83. Trivedi, P. J., Bruns, T., Ward, S., Mai, M., Schmidt, C., Hirschfield, G. M., Weston, C. J., Adams, D. H. (2016) Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity. J. Autoimmun. 68, 98–104.
84. Linton, L., Karlsson, M., Grundström, J., Hjalmarsson, E., Lindberg, A., Lindh, E., Glise, H., Befrits, R., Janczewska, I., Karlén, P., Winqvist, O., Eberhardson, M. (2012) HLA-DR (hi) and CCR9 define a proinflammatory monocyte subset in IBD. Clin. Transl. Gastroenterol. 3, e29.
85. Lee, S., Heinrich, E. L., Li, L., Lu, J., Choi, A. H., Levy, R. A., Wagner, J. E., Yip, M. L., Vaidehi, N., Kim, J. (2015) CCR9-mediated signaling through b-catenin and identification of a novel CCR9 antagonist. Mol. Oncol. 9, 1599–1611.
86. Drakes, M. L., Stiff, P. J., Blanchard, T. G. (2009) Inverse relationship between dendritic cell CCR9 expression and maturation state. Immunology 127, 466–476.
87. Hadeiba, H., Sato, T., Habtezion, A., Oderup, C., Pan, J., Butcher, E. C. (2008) CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 9, 1253–1260.
88. Johansson-Lindbom, B., Svensson, M., Pabst, O., Palmqvist, C., Marquez, G., Förster, R., Agace, W. W. (2005) Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J. Exp. Med. 202, 1063–1073.
89. Raverdeau, M., Mills, K. H. (2014) Modulation of T cell and innate immune responses by retinoic Acid. J. Immunol. 192, 2953–2958.
90. Hieshima, K., Kawasaki, Y., Hanamoto, H., Nakayama, T., Nagakubo, D., Kanamaru, A., Yoshie, O. (2004) CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells. J. Immunol. 173, 3668–3675.
91. Pabst, O., Ohl, L., Wendland, M., Wurbel, M. A., Kremmer, E., Malissen, B., Förster, R. (2004) Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine. J. Exp. Med. 199, 411–416.
92. Wurbel, M. A., McIntire, M. G., Dwyer, P., Fiebiger, E. (2011) CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis. PLoS One 6, e16442.
93. Evans-Marin, H. L., Cao, A. T., Yao, S., Chen, F., He, C., Liu, H., Wu, W., Gonzalez, M. G., Dann, S. M., Cong, Y. (2015) Unexpected regulatory role of CCR9 in regulatory T cell development. PLoS One 10, e0134100.
94. Rivera-Nieves, J., Ho, J., Bamias, G., Ivashkina, N., Ley, K., Oppermann, M., Cominelli, F. (2006) Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis. Gastroenterology 131, 1518–1529.
95. Wendt, E., Keshav, S. (2015) CCR9 antagonism: potential in the treatment of inflammatory bowel disease. Clin. Exp. Gastroenterol. 8, 119–130.
96. Pan, J., Kunkel, E. J., Gosslar, U., Lazarus, N., Langdon, P., Broadwell, K., Vierra, M. A., Genovese, M. C., Butcher, E. C., Soler, D. (2000) A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J. Immunol. 165, 2943–2949.
97. Wang, W., Soto, H., Oldham, E. R., Buchanan, M. E., Homey, B., Catron, D., Jenkins, N., Copeland, N. G., Gilbert, D. J., Nguyen, N., Abrams, J., Kershenovich, D., Smith, K., McClanahan, T., Vicari, A. P., Zlotnik, A. (2000) Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J. Biol. Chem. 275, 22313–22323.
98. Hu, S., Yang, K., Yang, J., Li, M., Xiong, N. (2011) Critical roles of chemokine receptor CCR10 in regulating memory IgA responses in intestines. Proc. Natl. Acad. Sci. USA 108, E1035–E1044.
99. Berri, M., Virlogeux-Payant, I., Chevaleyre, C., Melo, S., Zanello, G., Salmon, H., Meurens, F. (2014) CCL28 involvement in mucosal tissues protection as a chemokine and as an antibacterial peptide. Dev. Comp. Immunol. 44, 286–290.
100. Maeda, S., Ohno, K., Nakamura, K., Uchida, K., Nakashima, K., Fukushima, K., Tsukamoto, A., Goto-Koshino, Y., Fujino, Y., Tsujimoto, H. (2011) Quantification of chemokine and chemokine receptor gene expression in duodenal mucosa of dogs with inflammatory bowel disease. Vet. Immunol. Immunopathol. 144, 290–298.
101. Ogawa, H., Iimura, M., Eckmann, L., Kagnoff, M. F. (2004) Regulated production of the chemokine CCL28 in human colon epithelium. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G1062–G1069.
102. Eksteen, B., Miles, A., Curbishley, S. M., Tselepis, C., Grant, A. J., Walker, L. S., Adams, D. H. (2006) Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10. J. Immunol. 177, 593–603.
103. Kunkel, E. J., Kim, C. H., Lazarus, N. H., Vierra, M. A., Soler, D., Bowman, E. P., Butcher, E. C. (2003) CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J. Clin. Invest. 111, 1001–1010.
104. Morteau, O., Gerard, C., Lu, B., Ghiran, S., Rits, M., Fujiwara, Y., Law, Y., Distelhorst, K., Nielsen, E. M., Hill, E. D., Kwan, R., Lazarus, N. H., Butcher, E. C., Wilson, E. (2008) An indispensable role for the chemokine receptor CCR10 in IgA antibody-secreting cell accumulation. J. Immunol. 181, 6309–6315.
105. Kraynyak, K. A., Kutzler, M. A., Cisper, N. J., Khan, A. S., Draghia-Akli, R., Sardesal, N. Y., Lewis, M. G., Yan, J., Weiner, D. B. (2010) Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques. Vaccine 28, 1942–1951.
106. Kutzler, M. A., Kraynyak, K. A., Nagle, S. J., Parkinson, R. M., Zharikova, D., Chattergoon, M., Maguire, H., Muthumani, K., Ugen, K., Weiner, D. B. (2010) Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo. Gene Ther. 17, 72–82.
107. Chabot, S., Wagner, J. S., Farrant, S., Neutra, M. R. (2006) TLRs regulate the gatekeeping functions of the intestinal follicle-associated epithelium. J. Immunol. 176, 4275–4283.
108. Lee, J., Mo, J. H., Katakura, K., Alkalay, I., Rucker, A. N., Liu, Y. T., Lee, H. K., Shen, C., Cojocaru, G., Shenouda, S., Kagnoff, M., Eckmann, L., Ben-Neriah, Y., Raz, E. (2006) Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat. Cell Biol. 8, 1327–1336.
109. Bambou, J. C., Giraud, A., Menard, S., Begue, B., Rakotobe, S., Heyman, M., Taddei, F., Cerf-Bensussan, N., Gaboriau-Routhiau, V. (2004) In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain. J. Biol. Chem. 279, 42984–42992.
110. Baggiolini, M., Dewald, B., Moser, B. (1997) Human chemokines: an update. Annu. Rev. Immunol. 15, 675–705.
111. Holmes, W. E., Lee, J., Kuang, W. J., Rice, G. C., Wood, W. I. (2009) Structure and functional expression of a human interleukin-8 receptor. Science. 1991. 253: 1278–1280. J. Immunol. 183, 2895–2897.
112. Lee, J., Horuk, R., Rice, G. C., Bennett, G. L., Camerato, T., Wood, W. I. (1992) Characterization of two high affinity human interleukin-8 receptors. J. Biol. Chem. 267, 16283–16287.
113. Addison, C. L., Daniel, T. O., Burdick, M. D., Liu, H., Ehlert, J. E., Xue, Y. Y., Buechi, L., Walz, A., Richmond, A., Strieter, R. M. (2000) The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J. Immunol. 165, 5269–5277.
114. Sturm, A., Baumgart, D. C., d’Heureuse, J. H., Hotz, A., Wiedenmann, B., Dignass, A. U. (2005) CXCL8 modulates human intestinal epithelial cells through a CXCR1 dependent pathway. Cytokine 29, 42–48.
115. Daig, R., Andus, T., Aschenbrenner, E., Falk, W., Schölmerich, J., Gross, V. (1996) Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 38, 216–222.
116. Aarntzen, E. H., Hermsen, R., Drenth, J. P., Boerman, O. C., Oyen, W. J. (2016) 99mTc-CXCL8 SPECT to monitor disease activity in inflammatory bowel disease. J. Nucl. Med. 57, 398–403.
117. Jijon, H. B., Panenka, W. J., Madsen, K. L., Parsons, H. G. (2002) MAP kinases contribute to IL-8 secretion by intestinal epithelial cells via a posttranscriptional mechanism. Am. J. Physiol. Cell Physiol. 283, C31–C41.
118. Brand, S., Sakaguchi, T., Gu, X., Colgan, S. P., Reinecker, H. C. (2002) Fractalkine-mediated signals regulate cell-survival and immunemodulatory responses in intestinal epithelial cells. Gastroenterology 122, 166–177.
119. Lammers, K. M., Lu, R., Brownley, J., Lu, B., Gerard, C., Thomas, K., Rallabhandi, P., Shea-Donohue, T., Tamiz, A., Alkan, S., Netzel-Arnett, S., Antalis, T., Vogel, S. N., Fasano, A. (2008) Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 135, 194–204.e3.
120. Dwinell, M. B., Lügering, N., Eckmann, L., Kagnoff, M. F. (2001) Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterology 120, 49–59.
121. Chami, B., Yeung, A. W., van Vreden, C., King, N. J., Bao, S. (2014) The role of CXCR3 in DSS-induced colitis. PLoS One 9, e101622.
122. Suzuki, K., Kawauchi, Y., Palaniyandi, S. S., Veeraveedu, P. T., Fujii, M., Yamagiwa, S., Yoneyama, H., Han, G. D., Kawachi, H., Okada, Y., Ajioka, Y., Watanabe, K., Hosono, M., Asakura, H., Aoyagi, Y., Narumi, S. (2007) Blockade of interferon-gamma-inducible protein-10 attenuates chronic experimental colitis by blocking cellular trafficking and protecting intestinal epithelial cells. Pathol. Int. 57, 413–420.
123. Murakami, T., Kawada, K., Iwamoto, M., Akagami, M., Hida, K., Nakanishi, Y., Kanda, K., Kawada, M., Seno, H., Taketo, M. M., Sakai, Y. (2013) The role of CXCR3 and CXCR4 in colorectal cancer metastasis. Int. J. Cancer 132, 276–287.
124. Lee, J. W., Bajwa, P. J., Carson, M. J., Jeske, D. R., Cong, Y., Elson, C. O., Lytle, C., Straus, D. S. (2007) Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice. Gastroenterology 133, 108–123.
125. Wadwa, M., Klopfleisch, R., Adamczyk, A., Frede, A., Pastille, E., Mahnke, K., Hansen, W., Geffers, R., Lang, K. S., Buer, J., Büning, J., Westendorf, A. M. (2016) IL-10 downregulates CXCR3 expression on Th1 cells and interferes with their migration to intestinal inflammatory sites. Mucosal Immunol. 9, 1263–1277.
126. Müller, M., Carter, S., Hofer, M. J., Campbell, I. L. (2010) Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity—a tale of conflict and conundrum. Neuropathol. Appl. Neurobiol. 36, 368–387.
127. Groom, J. R., Luster, A. D. (2011) CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 89, 207–215.
128. Christen, U., McGavern, D. B., Luster, A. D., von Herrath, M. G., Oldstone, M. B. (2003) Among CXCR3 chemokines, IFN-gammainducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J. Immunol. 171, 6838–6845.
129. Lee, E. Y., Lee, Z. H., Song, Y. W. (2013) The interaction between CXCL10 and cytokines in chronic inflammatory arthritis. Autoimmun. Rev. 12, 554–557.
130. Marchi, L. F., Sesti-Costa, R., Ignacchiti, M. D., Chedraoui-Silva, S., Mantovani, B. (2014) In vitro activation of mouse neutrophils by recombinant human interferon-gamma: increased phagocytosis and release of reactive oxygen species and pro-inflammatory cytokines. Int. Immunopharmacol. 18, 228–235.
131. Agace, W. W., Amara, A., Roberts, A. I., Pablos, J. L., Thelen, S., Uguccioni, M., Li, X. Y., Marsal, J., Arenzana-Seisdedos, F., Delaunay, T., Ebert, E. C., Moser, B., Parker, C. M. (2000) Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation. Curr. Biol. 10, 325–328.
132. Jordan, N. J., Kolios, G., Abbot, S. E., Sinai, M. A., Thompson, D. A., Petraki, K., Westwick, J. (1999) Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J. Clin. Invest. 104, 1061–1069.
133. Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., Yoshida, N., Kikutani, H., Kishimoto, T. (1996) Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382, 635–638.
134. Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S., Kishimoto, T., Nagasawa, T. (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393, 591–594.
135. Ma, Q., Jones, D., Borghesani, P. R., Segal, R. A., Nagasawa, T., Kishimoto, T., Bronson, R. T., Springer, T. A. (1998) Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4-and SDF-1-deficient mice. Proc. Natl. Acad. Sci. USA 95, 9448–9453.
136. Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E., Sunshine, M. J., Littman, D. R., Kuo, C. J., Wei, K., McMaster, B. E., Wright, K., Howard, M. C., Schall, T. J. (2006) A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203, 2201–2213.
137. Sierro, F., Biben, C., Martínez-Muñoz, L., Mellado, M., Ransohoff, R. M., Li, M., Woehl, B., Leung, H., Groom, J., Batten, M., Harvey, R. P., Martínez A C., Mackay, C. R., Mackay, F. (2007) Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc. Natl. Acad. Sci. USA 104, 14759–14764.
138. Werner, L., Elad, H., Brazowski, E., Tulchinsky, H., Vigodman, S., Kopylov, U., Halpern, Z., Guzner-Gur, H., Dotan, I. (2011) Reciprocal regulation of CXCR4 and CXCR7 in intestinal mucosal homeostasis and inflammatory bowel disease. J. Leukoc. Biol. 90, 583–590.
139. Dwinell, M. B., Ogawa, H., Barrett, K. E., Kagnoff, M. F. (2004) SDF-1/ CXCL12 regulates cAMP production and ion transport in intestinal epithelial cells via CXCR4. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G844–G850.
140. Yu, Y., Chadee, K. (1998) Prostaglandin E2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism. J. Immunol. 161, 3746–3752.
141. Zimmerman, N. P., Vongsa, R. A., Faherty, S. L., Salzman, N. H., Dwinell, M. B. (2011) Targeted intestinal epithelial deletion of the chemokine receptor CXCR4 reveals important roles for extracellularregulated kinase-1/2 in restitution. Lab. Invest. 91, 1040–1055.
142. Oyama, T., Miura, S., Watanabe, C., Hokari, R., Fujiyama, Y., Komoto, S., Tsuzuki, Y., Hosoe, N., Nagata, H., Hibi, T. (2007) CXCL12 and CCL20 play a significant role in mucosal T-lymphocyte adherence to intestinal microvessels in mice. Microcirculation 14, 753–766.
143. Campbell, J. J., Hedrick, J., Zlotnik, A., Siani, M. A., Thompson, D. A., Butcher, E. C. (1998) Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279, 381–384.
144. Hosomi, S., Oshitani, N., Kamata, N., Sogawa, M., Okazaki, H., Tanigawa, T., Yamagami, H., Watanabe, K., Tominaga, K., Watanabe, T., Fujiwara, Y., Maeda, K., Hirakawa, K., Arakawa, T. (2011) Increased numbers of immature plasma cells in peripheral blood specifically overexpress chemokine receptor CXCR3 and CXCR4 in patients with ulcerative colitis. Clin. Exp. Immunol. 163, 215–224.
145. Uo, M., Hisamatsu, T., Miyoshi, J., Kaito, D., Yoneno, K., Kitazume, M. T., Mori, M., Sugita, A., Koganei, K., Matsuoka, K., Kanai, T., Hibi, T. (2013) Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcgR-mediated CD14 macrophage activation. Gut 62, 1734–1744.
146. Werner, L., Guzner-Gur, H., Dotan, I. (2013) Involvement of CXCR4/CXCR7/CXCL12 interactions in inflammatory bowel disease. Theranostics 3, 40–46.
147. Mrowicki, J., Przybylowska-Sygut, K., Dziki, L., Sygut, A., Chojnacki, J., Dziki, A., Majsterek, I. (2014) The role of polymorphisms of genes CXCL12/CXCR4 and MIF in the risk development IBD the Polish population. Mol. Biol. Rep. 41, 4639–4652.
148. Schulz, O., Jaensson, E., Persson, E. K., Liu, X., Worbs, T., Agace, W. W., Pabst, O. (2009) Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J. Exp. Med. 206, 3101–3114.
149. Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., Littman, D. R., Reinecker, H. C. (2005) CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307, 254–258.
150. Kayama, H., Ueda, Y., Sawa, Y., Jeon, S. G., Ma, J. S., Okumura, R., Kubo, A., Ishii, M., Okazaki, T., Murakami, M., Yamamoto, M., Yagita, H., Takeda, K. (2012) Intestinal CX3C chemokine receptor 1 (high) (CX3CR1 (high)) myeloid cells prevent T-cell-dependent colitis. Proc. Natl. Acad. Sci. USA 109, 5010–5015.
151. Kang, S., Okuno, T., Takegahara, N., Takamatsu, H., Nojima, S., Kimura, T., Yoshida, Y., Ito, D., Ohmae, S., You, D. J., Toyofuku, T., Jang, M. H., Kumanogoh, A. (2012) Intestinal epithelial cell-derived semaphorin 7A negatively regulates development of colitis via avb1 integrin. J. Immunol. 188, 1108–1116.
152. Medina-Contreras, O., Geem, D., Laur, O., Williams, I. R., Lira, S. A., Nusrat, A., Parkos, C. A., Denning, T. L. (2011) CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J. Clin. Invest. 121, 4787–4795.
153. Solari, R., Pease, J. E., Begg, M. (2015) “Chemokine receptors as therapeutic targets: Why aren’t there more drugs?”. Eur. J. Pharmacol. 746, 363–367.
154. Nishimura, M., Kuboi, Y., Muramoto, K., Kawano, T., Imai, T. (2009) Chemokines as novel therapeutic targets for inflammatory bowel disease. Ann. N. Y. Acad. Sci. 1173, 350–356.
155. Jähnichen, S., Blanchetot, C., Maussang, D., Gonzalez-Pajuelo, M., Chow, K. Y., Bosch, L., De Vrieze, S., Serruys, B., Ulrichts, H., Vandevelde, W., Saunders, M., De Haard, H. J., Schols, D., Leurs, R., Vanlandschoot, P., Verrips, T., Smit, M. J. (2010) CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells. Proc. Natl. Acad. Sci. USA 107, 20565–20570.
156. Walters, M. J., Wang, Y., Lai, N., Baumgart, T., Zhao, B. N., Dairaghi, D. J., Bekker, P., Ertl, L. S., Penfold, M. E., Jaen, J. C., Keshav, S., Wendt, E., Pennell, A., Ungashe, S., Wei, Z., Wright, J. J., Schall, T. J. (2010) Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease. J. Pharmacol. Exp. Ther. 335, 61–69.
157. Zhang, J., Romero, J., Chan, A., Goss, J., Stucka, S., Cross, J., Chamberlain, B., Varoglu, M., Chandonnet, H., Ryan, D., Lippa, B. (2015) Biarylsulfonamide CCR9 inhibitors for inflammatory bowel disease. Bioorg. Med. Chem. Lett. 25, 3661–3664.
158. Eksteen, B., Adams, D. H. (2010) GSK-1605786, a selective smallmolecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn’s disease. IDrugs 13, 472–481.
159. Allegretti, M., Cesta, M. C., Garin, A., Proudfoot, A. E. (2012) Current status of chemokine receptor inhibitors in development. Immunol. Lett. 145, 68–78.
160. Rogler, G. (2015) Where are we heading to in pharmacological IBD therapy? Pharmacol. Res. 100, 220–227.
161. Pierau, M., Engelmann, S., Reinhold, D., Lapp, T., Schraven, B., Bommhardt, U. H. (2009) Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation. J. Immunol. 183, 6124–6134.
162. Haxhinasto, S., Mathis, D., Benoist, C. (2008) The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205, 565–574.
163. Lu, L., Wang, J., Zhang, F., Chai, Y., Brand, D., Wang, X., Horwitz, D. A., Shi, W., Zheng, S. G. (2010) Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. J. Immunol. 184, 4295–4306.
164. Webb, A., Johnson, A., Fortunato, M., Platt, A., Crabbe, T., Christie, M. I., Watt, G. F., Ward, S. G., Jopling, L. A. (2008) Evidence for PI-3Kdependent migration of Th17-polarized cells in response to CCR2 and CCR6 agonists. J. Leukoc. Biol. 84, 1202–1212.
165. Fu, G., Chen, Y., Yu, M., Podd, A., Schuman, J., He, Y., Di, L., Yassai, M., Haribhai, D., North, P. E., Gorski, J., Williams, C. B., Wang, D., Wen, R. (2010) Phospholipase Cgamma1 is essential for T cell development, activation, and tolerance. J. Exp. Med. 207, 309–318.
166. Mor, A., Keren, G., Kloog, Y., George, J. (2008) N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells. Eur. J. Immunol. 38, 1493–1502.
167. Reinecker, H. C., Loh, E. Y., Ringler, D. J., Mehta, A., Rombeau, J. L., MacDermott, R. P. (1995) Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 108, 40–50.
168. Popivanova, B. K., Kostadinova, F. I., Furuichi, K., Shamekh, M. M., Kondo, T., Wada, T., Egashira, K., Mukaida, N. (2009) Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. Cancer Res. 69, 7884–7892.
169. Ajuebor, M. N., Hogaboam, C. M., Kunkel, S. L., Proudfoot, A. E., Wallace, J. L. (2001) The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. J. Immunol. 166, 552–558.
170. Zhao, X., Sato, A., Dela Cruz, C. S., Linehan, M., Luegering, A., Kucharzik, T., Shirakawa, A. K., Marquez, G., Farber, J. M., Williams, I., Iwasaki, A. (2003) CCL9 is secreted by the follicle-associated epithelium and recruits dome region Peyer’s patch CD11b+ dendritic cells. J. Immunol. 171, 2797–2803.
171. Kitaura, M., Nakajima, T., Imai, T., Harada, S., Combadiere, C., Tiffany, H. L., Murphy, P. M., Yoshie, O. (1996) Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J. Biol. Chem. 271, 7725–7730.
172. Kaser, A., Ludwiczek, O., Holzmann, S., Moschen, A. R., Weiss, G., Enrich, B., Graziadei, I., Dunzendorfer, S., Wiedermann, C. J., Mürzl, E., Grasl, E., Jasarevic, Z., Romani, N., Offner, F. A., Tilg, H. (2004) Increased expression of CCL20 in human inflammatory bowel disease. J. Clin. Immunol. 24, 74–85.
173. Skovdahl, H. K., Granlund, Av., Østvik, A. E., Bruland, T., Bakke, I., Torp, S. H., Damås, J. K., Sandvik, A. K. (2015) Expression of CCL20 and its corresponding receptor CCR6 is enhanced in active inflammatory bowel disease, and TLR3 mediates CCL20 expression in colonic epithelial cells. PLoS One 10, e0141710.
174. Zhang, H., Zhong, W., Zhou, G., Ding, X., Chen, H. (2012) Expression of chemokine CCL20 in ulcerative colitis. Mol. Med. Rep. 6, 1255–1260.
175. Esplugues, E., Huber, S., Gagliani, N., Hauser, A. E., Town, T., Wan, Y. Y., O’Connor, W., Jr., Rongvaux, A., Van Rooijen, N., Haberman, A. M., Iwakura, Y., Kuchroo, V. K., Kolls, J. K., Bluestone, J. A., Herold, K. C., Flavell, R. A. (2011) Control of TH17 cells occurs in the small intestine. Nature 475, 514–518.
176. Teramoto, K., Miura, S., Tsuzuki, Y., Hokari, R., Watanabe, C., Inamura, T., Ogawa, T., Hosoe, N., Nagata, H., Ishii, H., Hibi, T. (2005) Increased lymphocyte trafficking to colonic microvessels is dependent on MAdCAM-1 and C-C chemokine mLARC/CCL20 in DSS-induced mice colitis. Clin. Exp. Immunol. 139, 421–428.
177. Berin, M. C., Dwinell, M. B., Eckmann, L., Kagnoff, M. F. (2001) Production of MDC/CCL22 by human intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G1217–G1226.
178. Scheerens, H., Hessel, E., de Waal-Malefyt, R., Leach, M. W., Rennick, D. (2001) Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-102/2 mice and Rag-22/2 mice reconstituted with CD4+CD45RBhigh T cells. Eur. J. Immunol. 31, 1465–1474.
179. Torrente, F., Barabino, A., Bellini, T., Murch, S. H. (2014) Intraepithelial lymphocyte eotaxin-2 expression and perineural mast cell degranulation differentiate allergic/eosinophilic colitis from classic IBD. J. Pediatr. Gastroenterol. Nutr. 59, 300–307.
180. Ericsson, A., Kotarsky, K., Svensson, M., Sigvardsson, M., Agace, W. (2006) Functional characterization of the CCL25 promoter in small intestinal epithelial cells suggests a regulatory role for caudal-related homeobox (Cdx) transcription factors. J. Immunol. 176, 3642–3651.
181. Blanchard, C., Durual, S., Estienne, M., Emami, S., Vasseur, S., Cuber, J. C. (2005) Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is up-regulated by interleukin-4 and interleukin-13 via the signal transducer and activator of transcription 6. Int. J. Biochem. Cell Biol. 37, 2559–2573.
182. Hieshima, K., Ohtani, H., Shibano, M., Izawa, D., Nakayama, T., Kawasaki, Y., Shiba, F., Shiota, M., Katou, F., Saito, T., Yoshie, O. (2003) CCL28 has dual roles in mucosal immunity as a chemokine with broadspectrum antimicrobial activity. J. Immunol. 170, 1452–1461.
183. Puleston, J., Cooper, M., Murch, S., Bid, K., Makh, S., Ashwood, P., Bingham, A. H., Green, H., Moss, P., Dhillon, A., Morris, R., Strobel, S., Gelinas, R., Pounder, R. E., Platt, A. (2005) A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. Aliment. Pharmacol. Ther. 21, 109–120.
184. Yang, S. K., Choi, M. S., Kim, O. H., Myung, S. J., Jung, H. Y., Hong, W. S., Kim, J. H., Min, Y. I. (2002) The increased expression of an array of C-X-C and C-C chemokines in the colonic mucosa of patients with ulcerative colitis: regulation by corticosteroids. Am. J. Gastroenterol. 97, 126–132.
185. Buanne, P., Di Carlo, E., Caputi, L., Brandolini, L., Mosca, M., Cattani, F., Pellegrini, L., Biordi, L., Coletti, G., Sorrentino, C., Fedele, G., Colotta, F., Melillo, G., Bertini, R. (2007) Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. J. Leukoc. Biol. 82, 1239–1246.
186. Ranganathan, P., Jayakumar, C., Manicassamy, S., Ramesh, G. (2013) CXCR2 knockout mice are protected against DSS-colitis-induced acute kidney injury and inflammation. Am. J. Physiol. Renal Physiol. 305, F1422–F1427.
187. Z’Graggen, K., Walz, A., Mazzucchelli, L., Strieter, R. M., Mueller, C. (1997) The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease. Gastroenterology 113, 808–816.
188. Kwon, J. H., Keates, A. C., Anton, P. M., Botero, M., Goldsmith, J. D., Kelly, C. P. (2005) Topical antisense oligonucleotide therapy against LIX, an enterocyte-expressed CXC chemokine, reduces murine colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G1075–G1083.
189. Mazzucchelli, L., Hauser, C., Zgraggen, K., Wagner, H., Hess, M., Laissue, J. A., Mueller, C. (1994) Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am. J. Pathol. 144, 997–1007.
190. Rafferty, B. J., Unger, B. L., Perey, A. C., Tammariello, S. P., Pavlides, S., McGee, D. W. (2012) A novel role for the Rho-associated kinase, ROCK, in IL-1-stimulated intestinal epithelial cell responses. Cell. Immunol. 280, 148–155.
191. Egesten, A., Eliasson, M., Olin, A. I., Erjefält, J. S., Bjartell, A., Sangfelt, P., Carlson, M. (2007) The proinflammatory CXC-chemokines GROalpha/ CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids. Int. J. Colorectal Dis. 22, 1421–1427.
192. Ito, R., Shin-Ya, M., Kishida, T., Urano, A., Takada, R., Sakagami, J., Imanishi, J., Kita, M., Ueda, Y., Iwakura, Y., Kataoka, K., Okanoue, T., Mazda, O. (2006) Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin. Exp. Immunol. 146, 330–338.
193. Schroepf, S., Kappler, R., Brand, S., Prell, C., Lohse, P., Glas, J., Hoster, E., Helmbrecht, J., Ballauff, A., Berger, M., von Schweinitz, D., Koletzko, S., Lacher, M. (2010) Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease. Inflamm. Bowel Dis. 16, 1882–1890.
194. Sasaki, S., Yoneyama, H., Suzuki, K., Suriki, H., Aiba, T., Watanabe, S., Kawauchi, Y., Kawachi, H., Shimizu, F., Matsushima, K., Asakura, H., Narumi, S. (2002) Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival. Eur. J. Immunol. 32, 3197–3205.
195. Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Stevens, S., Flavell, R. A. (2008) Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29, 947–957.
196. Katsuta, T., Lim, C., Shimoda, K., Shibuta, K., Mitra, P., Banner, B. F., Mori, M., Barnard, G. F. (2000) Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease. Am. J. Gastroenterol. 95, 3157–3164.
197. Mikami, S., Nakase, H., Yamamoto, S., Takeda, Y., Yoshino, T., Kasahara, K., Ueno, S., Uza, N., Oishi, S., Fujii, N., Nagasawa, T., Chiba, T. (2008) Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis. J. Pharmacol. Exp. Ther. 327, 383–392.
198. Carlsen, H. S., Baekkevold, E. S., Johansen, F. E., Haraldsen, G., Brandtzaeg, P. (2002) B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue. Gut 51, 364–371.
199. Marchesi, F., Martin, A. P., Thirunarayanan, N., Devany, E., Mayer, L., Grisotto, M. G., Furtado, G. C., Lira, S. A. (2009) CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissueinducer cells, and formation of isolated lymphoid follicles. Mucosal Immunol. 2, 486–494.
200. Muehlhoefer, A., Saubermann, L. J., Gu, X., Luedtke-Heckenkamp, K., Xavier, R., Blumberg, R. S., Podolsky, D. K., MacDermott, R. P., Reinecker, H. C. (2000) Fractalkine is an epithelial and endothelial cellderived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J. Immunol. 164, 3368–3376.
201. Lucas, A. D., Chadwick, N., Warren, B. F., Jewell, D. P., Gordon, S., Powrie, F., Greaves, D. R. (2001) The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am. J. Pathol. 158, 855–866.
202. Kim, K. W., Vallon-Eberhard, A., Zigmond, E., Farache, J., Shezen, E., Shakhar, G., Ludwig, A., Lira, S. A., Jung, S. (2011) In vivo structure/function and expression analysis of the CX3C chemokine fractalkine. Blood 118, e156–e167.
203. Middel, P., Thelen, P., Blaschke, S., Polzien, F., Reich, K., Blaschke, V., Wrede, A., Hummel, K. M., Gunawan, B., Radzun, H. J. (2001) Expression of the T-cell chemoattractant chemokine lymphotactin in Crohn’s disease. Am. J. Pathol. 159, 1751–1761.
204. Berahovich, R. D., Miao, Z., Wang, Y., Premack, B., Howard, M. C., Schall, T. J. (2005) Proteolytic activation of alternative CCR1 ligands in inflammation. J. Immunol. 174, 7341–7351.
205. Imai, T., Baba, M., Nishimura, M., Kakizaki, M., Takagi, S., Yoshie, O. (1997) The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 272, 15036–15042.
206. Rossi, O., Karczewski, J., Stolte, E. H., Brummer, R. J., van Nieuwenhoven, M. A., Meijerink, M., van Neerven, J. R., van Ijzendoorn, S. C., van Baarlen, P., Wells, J. M. (2013) Vectorial secretion of interleukin-8 mediates autocrine signalling in intestinal epithelial cells via apically located CXCR1. BMC Res. Notes 6, 431.
207. Williams, E. J., Haque, S., Banks, C., Johnson, P., Sarsfield, P., Sheron, N. (2000) Distribution of the interleukin-8 receptors, CXCR1 and CXCR2, in inflamed gut tissue. J. Pathol. 192, 533–539.
208. Wu, W., Sun, C., Xu, D., Zhang, X., Shen, W., Lv, Y., Ma, T. (2015) Expression of CXCR2 and its clinical significance in human colorectal cancer. Int. J. Clin. Exp. Med. 8, 5883–5889.
209. Lasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., Mazzinghi, B., Orlando, C., Maggi, E., Marra, F., Romagnani, S., Serio, M., Romagnani, P. (2003) An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 197, 1537–1549.
210. Smith, J. M., Johanesen, P. A., Wendt, M. K., Binion, D. G., Dwinell, M. B. (2005) CXCL12 activation of CXCR4 regulates mucosal host defense through stimulation of epithelial cell migration and promotion of intestinal barrier integrity. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G316–G326.